Dr. Jörg Windisch
Dr. Windisch has worked in the biotech industry for the last 27 years, having served as CSO of Sandoz Biopharmaceuticals, COO of Affimed, and CEO of Polpharma Biologics. He has experience in drug development, regulatory affairs (EMA and FDA), manufacturing, quality, program management and general leadership of biotech and pharma companies.
He has brought several products from project initiation all the way to the market in Europe and the US. Dr. Windisch holds a Ph.D. in biochemistry, has published widely in the field, and is an inventor on many patents.
